These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6653617)

  • 61. [Pipemidic acid: a new antibiotic for the urinary tract. A comparative, double-blind study of pipemidic acid and amoxidillin].
    Oosterlinck W; Welvaert P; Verbaeys A; Schelfout W; Wijndaele JJ; de Maeyer P
    Acta Urol Belg; 1980 Oct; 48(4):471-7. PubMed ID: 7006346
    [No Abstract]   [Full Text] [Related]  

  • 62. Studies on cinoxacin. 3. Concentrations of cinoxacin in serum, urine and tissues of urological patients.
    Colleen S; Andersson KE; Mårdh PA
    J Antimicrob Chemother; 1977 Nov; 3(6):579-84. PubMed ID: 599120
    [No Abstract]   [Full Text] [Related]  

  • 63. [Clinical effectiveness of pipemidic acid on gonorrhoeal urethritis].
    Yasumoto R; Morikawa Y; Horii A; Kawakita J; Kobayakawa H; Wada S; Sakamoto W; Ozaki Y; Nishijima T
    Hinyokika Kiyo; 1985 Jan; 31(1):193-6. PubMed ID: 3993494
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Toyonaga Y; Kurosu Y; Sugita M; Nakamura H; Takahashi T; Hori M
    Jpn J Antibiot; 1985 Feb; 38(2):373-413. PubMed ID: 3847524
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Bacteriological, pharmacokinetic and clinical studies of SY5555 dry syrup in the pediatric field].
    Toyonaga Y; Ishihara T; Tezuka T; Nakamura H
    Jpn J Antibiot; 1995 Jan; 48(1):71-91. PubMed ID: 7699846
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Cinoxacin in infections of the lower urinary tract].
    Montefiore F; Bassi G; Laguzzi E; Mele L
    Minerva Med; 1988 Apr; 79(4):323-4. PubMed ID: 3368114
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Comparative evaluation of norfloxacin and cinoxacin in the therapy of complicated infections of the urinary tract].
    Cristiano P; Morelli G; Simioli F; Iovene MR; Della Vittoria Scarpati M; Manguso L
    Minerva Med; 1989 Apr; 80(4):393-5. PubMed ID: 2657499
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Comparative therapeutic evaluation of 2 quinolone derivatives, norfloxacin and cinoxacin, in complicated infections of the urinary tract].
    Tizzani A; Casetta G; Piana P
    Minerva Urol Nefrol; 1985; 37(4):489-92. PubMed ID: 3834630
    [No Abstract]   [Full Text] [Related]  

  • 69. The pharmacokinetics and availability of niflumic acid in humans.
    Houin G; Tremblay D; Bree F; Dufour A; Ledudal P; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1983 Mar; 21(3):130-4. PubMed ID: 6852999
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Basic and clinical studies on clarithromycin in pediatrics].
    Iwai N; Taneda Y; Miyazu M; Nakamura H; Kasai K
    Jpn J Antibiot; 1989 Feb; 42(2):304-22. PubMed ID: 2526244
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Successful use of reduced dosage of cinoxacin in the treatment of recurrent urinary infection.
    Brumfitt W; Smith GW; Hamilton-Miller JM; Bax R
    J Antimicrob Chemother; 1985 Dec; 16(6):781-8. PubMed ID: 4093347
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Transformation of cinoxacin by Beauveria bassiana.
    Parshikov IA; Moody JD; Heinze TM; Freeman JP; Williams AJ; Sutherland JB
    FEMS Microbiol Lett; 2002 Aug; 214(1):133-6. PubMed ID: 12204384
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Long-term low dose cinoxacin therapy for the prevention of recurrent urinary tract infections.
    Landes RR
    J Urol; 1980 Jan; 123(1):47-50. PubMed ID: 7351723
    [No Abstract]   [Full Text] [Related]  

  • 74. Simple method for the determination of pipemidic acid in biological fluids by high-performance liquid chromatography.
    Fukuhara K; Matsuki Y
    J Chromatogr; 1987 May; 416(2):409-13. PubMed ID: 3611274
    [No Abstract]   [Full Text] [Related]  

  • 75. Pharmacokinetics of cinoxacin in patients with renal failure.
    Szwed JJ; Brannon DE; Sloan RS; Luft FC
    J Antimicrob Chemother; 1978 Sep; 4(5):451-4. PubMed ID: 690045
    [No Abstract]   [Full Text] [Related]  

  • 76. Determination by high-performance liquid chromatography of pipemidic acid in human serum and urine.
    Smethurst AM; Mann WC
    J Chromatogr; 1983 May; 274():421-7. PubMed ID: 6874850
    [No Abstract]   [Full Text] [Related]  

  • 77. Complexation of antibacterial quinolonic acid and cinolonic derivatives with Zn(II) and Al(III): application to their determination in human urine.
    Durán Merás I; Muñoz de la Peña A; Salinas López F; Rodríguez Cáceres MI
    Analyst; 2000 Aug; 125(8):1471-6. PubMed ID: 11002930
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Norfloxacin, the first of a new class of fluoroquinolone antimicrobials, revisited.
    Gadebusch HH; Shungu DL
    Int J Antimicrob Agents; 1991; 1(1):3-28. PubMed ID: 18611490
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Derivatization-gas chromatographic analysis of cinoxacin in capsules as its pentafluorobenzyl derivative.
    Wang KJ; Chen SH; Lin SJ; Wu HL
    J Chromatogr; 1986 Jun; 360(2):443-8. PubMed ID: 3733950
    [No Abstract]   [Full Text] [Related]  

  • 80. Piperazine based antimicrobial polymers: a review.
    Jalageri MD; Nagaraja A; Puttaiahgowda YM
    RSC Adv; 2021 Apr; 11(25):15213-15230. PubMed ID: 35424074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.